Our next stem cells study

Post thumbnail

ClinMed is preparing to the next stem cells (ATMP) study

ClinMed Pharma (CRO, Poland) will conduct phase I study with stem cells in orphan disease as a full service CRO. It is the most innovative study on the clinical trials market with Advanced Therapy Medicinal Product.